PINL:OPTI - Post Discussion
Post by
whytestocks on Feb 12, 2024 4:30pm
Optimi Health Congratulates Lykos Therapeutics on FDA Priori
Breaking News: $OPTI Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production VideoVANCOUVER, British Columbia, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Health Canada licensed drug researcher and formulator specializing in controlled psychedelic substances such as n...
OPTI - Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production Video
Be the first to comment on this post